Mercados españoles cerrados

Akoya Biosciences, Inc. (AKYA)

NasdaqGS - NasdaqGS Precio en tiempo real. Divisa en USD
Añadir a la lista de favoritos
4,4900+0,3800 (+9,25%)
A partir del 01:09PM EDT. Mercado abierto.

Akoya Biosciences, Inc.

100 Campus Drive
6th Floor
Marlborough, MA 01752
United States
855 896 8401
https://www.akoyabio.com

Sector(es)Healthcare
SectorMedical Instruments & Supplies
Empleados a tiempo completo330

Ejecutivos clave

NombreTítuloPagaEjecutadoAño de nacimiento
Mr. Brian McKelligonPresident, CEO & Director854,99kN/A1969
Mr. John Frederick EkCFO, Principal Financial Officer & Principal Accounting Officer496,76kN/A1976
Dr. Frederic G. Pla Ph.D.Chief Operating Officer581,23kN/A1959
Priyam ShahSenior Director of Business Development & Investor Relations StrategyN/AN/AN/A
Ms. Jennifer KamocsayGeneral CounselN/AN/A1971
Dr. Niro Ramachandran Ph.D.Chief Business Officer298,18kN/A1975
Dr. Pascal Bamford Ph.D.Senior Vice President, Research & Development and Laboratory OperationsN/AN/AN/A
Mr. Rob C. Hart CFA, J.D.SecretaryN/AN/AN/A
Los importes son a partir de 31 de diciembre de 2023 y los valores de compensación son para el último año fiscal que finaliza en esa fecha. Paga es el salario, las bonificaciones, etc. Ejecutado es el valor de las opciones ejecutadas durante el año fiscal. Divisa en USD.

Descripción

Akoya Biosciences, Inc., a life sciences technology company, provides spatial biology solutions focused on transforming discovery and clinical research in North America, the Asia Pacific, Europe, the Middle East, and Africa. The company offers PhenoCycler instrument, a compact bench-top fluidics system that integrates with a companion microscope to automate image acquisition; and PhenoImager platform that enables researchers to visualize, analyze, quantify, and phenotype cells in situ, in fresh frozen or FFPE tissue sections, and tissue microarrays utilizing an automated and high-throughput workflow. It also provides PhenoCycler and PhenoImager reagents; and biopharma services. In addition, the company offers analysis software partnerships ecosystem; inForm Tissue, an automated image analysis software package for accurately visualizing and quantifying biomarkers in tissue sections; Phenoptr, which provides functions that consolidate and analyze output tables created by inForm software; and phenoptrReports, a software that generates shareable reports and visualizations based on the phenoptr output in an intuitive front-end GUI. The company was incorporated in 2015 and is headquartered in Marlborough, Massachusetts.

Gobierno corporativo

El ISS Governance QualityScore de Akoya Biosciences, Inc., a día 1 de mayo de 2024, es 7. Las puntuaciones base son Auditoría: 4; Tablero: 7; Derechos de los accionistas: 8; Compensación: 9.

Puntuación de gobierno corporativo cedida por Institutional Shareholder Services (ISS). Las puntuaciones indican un rango decil relativo al índice o región. Una puntuación decil de 1 indica un menor riesgo de gobierno, mientras que un 10 indica un riesgo de gobierno superior.